NCT01367587View on ClinicalTrials.gov

Safety and Gastrointestinal Effects of Intravenous Methylnaltrexone

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

July 31, 2002

Study Completion Date

July 31, 2002

Conditions
Healthy Volunteers
Interventions
DRUG

IV Methylnaltrexone

Trial Locations (1)

10591

Progenics Pharmaceuticals, Inc., Tarrytown

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT01367587 - Safety and Gastrointestinal Effects of Intravenous Methylnaltrexone | Biotech Hunter | Biotech Hunter